Schueller G, Paolini P, Friedl J, Stift A, Dubsky P, Bachleitner-Hofmann T, Jakesz R, Gnant M
Department of Surgery, University Hospital Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
Anticancer Res. 2001 Jan-Feb;21(1A):295-300.
Immunotherapy, i.e. stimulation of the body's immune response against tumor cells, is a promising approach in cancer treatment. In this context, heat shock proteins (HSP) have been shown to function in tumor antigen chaperoning. HSP are evolutionarily conserved and show increased expression in response to chemical and physical stress. Two members of the HSP family, HSP 70 and 90, seem to further act as immunostimulating agents because of their possible involvement in tumor antigen presentation. We cultured the human hepatocellular carcinoma cell line HepG2 and investigated its HSP content under normal and hyperthermic conditions. Flow cytometry showed increased levels of HSP 70 and 90 after heat shock at 41.8 degrees C for 60 minutes, measured after a subsequent incubation time of five hours, as compared to untreated cells in vitro. We further observed a clear correlation between the HSP 70 and 90 levels and the necrotic cell subpopulation in heat shocked tumor cells. We conclude that HSP expression in HepG2 cells can be enhanced by heat shock treatment in vitro. We suggest that this mechanism can be exploited in increasing tumor immunogenicity.
免疫疗法,即刺激机体对肿瘤细胞的免疫反应,是癌症治疗中一种很有前景的方法。在此背景下,热休克蛋白(HSP)已被证明在肿瘤抗原伴侣作用中发挥功能。热休克蛋白在进化上是保守的,并且在化学和物理应激反应中表达增加。热休克蛋白家族的两个成员,HSP 70和90,似乎因其可能参与肿瘤抗原呈递而进一步充当免疫刺激剂。我们培养了人肝癌细胞系HepG2,并研究了其在正常和热疗条件下的热休克蛋白含量。流式细胞术显示,与体外未处理的细胞相比,在41.8摄氏度热休克60分钟后,经过随后5小时的孵育时间测量,HSP 70和90的水平有所增加。我们进一步观察到热休克肿瘤细胞中HSP 70和90水平与坏死细胞亚群之间存在明显的相关性。我们得出结论,体外热休克处理可增强HepG2细胞中的热休克蛋白表达。我们建议可以利用这种机制来提高肿瘤免疫原性。